AbbVie to Acquire ImmunoGen for US$10.1 B
By Lucy Haggerty
Pharma Deals Review: Vol 2023 Issue 12 (Table of Contents)
Published: 7 Dec-2023
DOI: 10.3833/pdr.v2023.i12.2841 ISSN: 1756-7874
Section: Mergers & Acquisitions
Fulltext:
Abstract
In order to expand its solid tumour portfolio, AbbVie has agreed to acquire ImmunoGen for US$31...
This page is available to subscribers only.
Not a subscriber? Join here
Already Registered? Please login using the top left purple box.
Copyright: © IQVIA 2018
RSS